Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Albuterol delivered by novel MSI system enters clinical evaluation

Dec. 2, 1998

Asthma program accelerated by Genome Therapeutics and Schering-Plough

Dec. 1, 1998

PDE4 inhibitor developed at Celltech superior to available antiasthmatic agents in rabbit model

Nov. 27, 1998

Montelukast shows synergistic efficacy with antihistamines in allergic rhinitis

Nov. 27, 1998

Targeted Genetics and Medeva form collaboration to develop CF treatment

Nov. 27, 1998

Noval antiasthmatic agent from Takeda with dual antiinflammatory and bronchodilating effects

Nov. 26, 1998

FK-3657: clinical candidate from novel class of nonpeptide BK antagonists

Nov. 26, 1998

NOS inhibitors claimed by Astra for use in inflammation and pain

Nov. 26, 1998

Pfizer claims new series for inhibiting PDE4 and TNF production

Nov. 26, 1998

Zyrtec available in Japan through UCB licensees

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...